These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 34345172)

  • 1. Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics.
    Allemailem KS; Almatroudi A; Alrumaihi F; Almatroodi SA; Alkurbi MO; Basfar GT; Rahmani AH; Khan AA
    Int J Nanomedicine; 2021; 16():5065-5098. PubMed ID: 34345172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations.
    S Allemailem K; Almatroudi A; Alsahli MA; Aljaghwani A; M El-Kady A; Rahmani AH; Khan AA
    Int J Nanomedicine; 2021; 16():3907-3936. PubMed ID: 34135584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional TPP-PEG-biotin self-assembled nanoparticle drug delivery-based combination therapeutic approach for co-targeting of GRP78 and lysosome.
    Purushothaman B; Lee J; Hong S; Song JM
    J Nanobiotechnology; 2020 Jul; 18(1):102. PubMed ID: 32690101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy.
    Domagala A; Fidyt K; Bobrowicz M; Stachura J; Szczygiel K; Firczuk M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30071644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lysosome-targeting drugs with anti-inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers.
    Hansen MB; Postol M; Tvingsholm S; Nielsen IØ; Dietrich TN; Puustinen P; Maeda K; Dinant C; Strauss R; Egan D; Jäättelä M; Kallunki T
    Cell Oncol (Dordr); 2021 Aug; 44(4):805-820. PubMed ID: 33939112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosome Membrane Permeabilization and Disruption of the Molecular Target of Rapamycin (mTOR)-Lysosome Interaction Are Associated with the Inhibition of Lung Cancer Cell Proliferation by a Chloroquinoline Analog.
    Sironi J; Aranda E; Nordstrøm LU; Schwartz EL
    Mol Pharmacol; 2019 Jan; 95(1):127-138. PubMed ID: 30409790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management.
    Allemailem KS
    Int J Nanomedicine; 2021; 16():8159-8184. PubMed ID: 34938075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism.
    Dielschneider RF; Eisenstat H; Mi S; Curtis JM; Xiao W; Johnston JB; Gibson SB
    Leukemia; 2016 Jun; 30(6):1290-300. PubMed ID: 26859075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
    Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
    Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells.
    Li Y; Sun Y; Jing L; Wang J; Yan Y; Feng Y; Zhang Y; Liu Z; Ma L; Diao A
    Chemotherapy; 2017; 62(2):85-93. PubMed ID: 27764836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
    Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
    Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death.
    Villamil Giraldo AM; Appelqvist H; Ederth T; Öllinger K
    Biochem Soc Trans; 2014 Oct; 42(5):1460-4. PubMed ID: 25233432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosome passivation triggered by silver nanoparticles enhances subcellular-targeted drug therapy.
    Wang X; Zhao S; Fang G; Wang R; Lyu X; Shao X; Ling P; Meng C; Chen J; Mu Y
    Nanoscale; 2024 May; 16(17):8597-8606. PubMed ID: 38602353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs.
    Ellegaard AM; Bach P; Jäättelä M
    Rev Physiol Biochem Pharmacol; 2023; 185():107-152. PubMed ID: 33398504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-resolution observation of lysosomal dynamics with fluorescent gold nanoparticles.
    Qiu K; Du Y; Liu J; Guan JL; Chao H; Diao J
    Theranostics; 2020; 10(13):6072-6081. PubMed ID: 32483439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
    Thambiraj S; Vijayalakshmi R; Ravi Shankaran D
    Sci Rep; 2021 Feb; 11(1):2808. PubMed ID: 33531521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer.
    Shirbhate E; Singh V; Mishra A; Jahoriya V; Veerasamy R; Tiwari AK; Rajak H
    Mini Rev Med Chem; 2024; 24(15):1449-1468. PubMed ID: 38343053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer.
    Feng J; Wang ZX; Bin JL; Chen YX; Ma J; Deng JH; Huang XW; Zhou J; Lu GD
    Cancer Lett; 2024 Apr; 587():216728. PubMed ID: 38431036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosome-targeted fluorescent probes: Design mechanism and biological applications.
    Duan X; Tong Q; Fu C; Chen L
    Bioorg Chem; 2023 Nov; 140():106832. PubMed ID: 37683542
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.